Keybank National Association OH Purchases 697,613 Shares of Axon Enterprise, Inc $AXON

Key Points

• Keybank National Association OH increased its Axon stake by 697,613 shares in the third quarter, a 68,460.5% rise, bringing its holdings to 698,632 shares valued at about $295.2 million. Axon represents 1% of the bank’s portfolio.
• Other institutional investors also added to positions, and hedge funds and institutional investors collectively own 79.08% of Axon’s shares.
• Axon’s latest quarterly results missed analyst expectations for both EPS and revenue, although revenue grew 27.8% year over year. Analysts’ consensus rating was “Moderate Buy,” with an average price target of $612.18.

Keybank National Association OH raised its position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 68,460.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 698,632 shares of the biotechnology company's stock after purchasing an additional 697,613 shares during the quarter. Axon Enterprise comprises 1.0% of Keybank National Association OH's investment portfolio, making the stock its 22nd biggest position. Keybank National Association OH owned 0.86% of Axon Enterprise worth $295,186,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. MassMutual Private Wealth & Trust FSB raised its position in Axon Enterprise by 122,993.6% in the third quarter. MassMutual Private Wealth & Trust FSB now owns 461,601 shares of the biotechnology company's stock valued at $195,036,000 after purchasing an additional 461,226 shares during the period. B. Metzler seel. Sohn & Co. AG acquired a new position in shares of Axon Enterprise in the 2nd quarter valued at $3,854,000. Arrowstreet Capital Limited Partnership acquired a new position in shares of Axon Enterprise in the 1st quarter valued at $15,067,000. Brown Lisle Cummings Inc. lifted its stake in shares of Axon Enterprise by 97,231.4% in the 2nd quarter. Brown Lisle Cummings Inc. now owns 34,066 shares of the biotechnology company's stock valued at $19,098,000 after purchasing an additional 34,031 shares during the last quarter. Finally, Harel Insurance Investments & Financial Services Ltd. lifted its stake in shares of Axon Enterprise by 40.7% in the 1st quarter. Harel Insurance Investments & Financial Services Ltd. now owns 15,083 shares of the biotechnology company's stock valued at $6,406,000 after purchasing an additional 4,360 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company's stock.

Axon Enterprise Stock Down 0.2%

Shares of NASDAQ AXON opened at $302.54 on Wednesday. The firm has a market cap of $24.58 billion, a price-to-earnings ratio of 96.97, a PEG ratio of 5.76 and a beta of 1.48. The company has a quick ratio of 2.60, a current ratio of 3.00 and a debt-to-equity ratio of 0.76. Axon Enterprise, Inc has a 52-week low of $291.45 and a 52-week high of $665.07. The business's 50 day moving average is $430.30 and its two-hundred day moving average is $472.14.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The biotechnology company reported $1.72 EPS for the quarter, missing analysts' consensus estimates of $1.89 by ($0.17). Axon Enterprise had a return on equity of 3.87% and a net margin of 7.56%. The firm had revenue of $908.55 million for the quarter, compared to analyst estimates of $934.33 million. During the same quarter last year, the company earned $1.17 earnings per share. The firm's revenue for the quarter was up 27.8% on a year-over-year basis. Research analysts predict that Axon Enterprise, Inc will post 2.10 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on AXON shares. Citigroup reiterated a "market outperform" rating on shares of Axon Enterprise in a report on Monday, November 2nd. Morgan Stanley boosted their price objective on shares of Axon Enterprise from $600.00 to $640.00 and gave the company an "overweight" rating in a report on Thursday, August 6th. JPMorgan Chase & Co. decreased their target price on shares of Axon Enterprise from $755.00 to $610.00 and set an "overweight" rating on the stock in a research report on Friday, November 6th. Zacks Research lowered shares of Axon Enterprise from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, November 3rd. Finally, Craig Hallum lowered shares of Axon Enterprise from a "buy" rating to a "hold" rating and set a $390.00 target price for the company. in a research note on Friday, November 6th. Thirteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, Axon Enterprise currently has an average rating of "Moderate Buy" and a consensus target price of $612.18.

Axon Enterprise News Roundup

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon is investing $1.2 billion for a 37% stake in drone maker Skydio and will become its U.S. public-safety distributor. The deal could broaden Axon’s public-safety technology offering, though its scale also brings investment and execution risks. Axon invests in Skydio
• Positive Sentiment: West Fargo police plan to replace Flock technology with Axon’s system, including new AI features—an example of continued adoption by public-safety customers. West Fargo police adoption
• Positive Sentiment: Despite lowering its price target, Barclays retained an “overweight” rating at $507; Northland reportedly still sees a $540 target after the stock’s steep fall from its August high. These views suggest some analysts see substantial recovery potential, though targets are not guarantees. Northland target outlook
• Neutral Sentiment: A short-interest report lists 0 shares short, despite describing a large increase. The figure appears inconsistent and does not provide a reliable indication of short-selling pressure.
• Negative Sentiment: Axon’s third-quarter adjusted EPS of $1.72 and revenue of about $909 million fell short of estimates. Cautious guidance and roughly $130 million in federal-contract revenue shifting out of 2026 have weighed on the outlook; shares have fallen sharply since the results, while Motorola rose after its earnings beat. Axon versus Motorola after earnings
• Negative Sentiment: Law firms announced investigations into potential securities-law violations. These are allegations under investigation, not findings of wrongdoing, but may add legal and reputational uncertainty for investors. Axon securities investigation notice

Insider Transactions at Axon Enterprise

In related news, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $508.99, for a total transaction of $5,089,900.00. Following the transaction, the chief executive officer owned 3,118,012 shares of the company's stock, valued at approximately $1,587,036,927.88. This represents a 0.32% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Isaiah Fields sold 1,017 shares of the firm's stock in a transaction dated Friday, September 11th. The shares were sold at an average price of $480.45, for a total value of $488,617.65. Following the transaction, the insider owned 56,264 shares of the company's stock, valued at $27,032,038.80. This trade represents a 1.78% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 37,397 shares of company stock valued at $21,234,034. Corporate insiders own 4.20% of the company's stock.

About Axon Enterprise

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.